We have located links that may give you full text access.
Long-term outcome of catheter ablation in post-infarction recurrent ventricular tachycardia.
Scandinavian Cardiovascular Journal : SCJ 2019 March 28
OBJECTIVES: Severe LV dysfunction and advanced age are associated with VT recurrence after catheter ablation in patients with post-infarction drug-refractory VT. We present retrospective analysis of long-term outcome after single and repeat VT ablation procedures in patients with ischemic heart disease.
DESIGN: Patients with recurrent VT post infarction who underwent catheter ablation between 2006 and 2017 in Isala Heart Centre were retrospectively analyzed. Univariate and multivariate analysis were used to identify predictors of arrhythmia recurrence post ablation. Patients were allocated to subgroups based on LVEF: severe (< 30%), moderate (30-40%) and mild LV dysfunction (41-51%) and analyzed with log rank test.
RESULTS: A total of 144 patients were included. Two years VT free survival after a single procedure was 56,6% with median follow-up 46 [17-78] months. Recurrence of VT postablation wash high among patients with an old anteroseptal MI and LVEF <30% with multiple morphologies of inducible VTs, indicating an extensive and complex substrate. Patients who underwent repeat ablations (27.1%) had significant more often LV aneurysms (20.5% vs 7.6%, p = 0.03) and electrical storms (38.5% vs 21.9%, p = 0.04). VT free survival was higher in patients with LVEF 41-51% compared to LVEF <30% (71.4% vs 47.8%, p = 0.01). In multivariate analysis, LVEF <30% (vs 41-51%) was an independent predictor of arrhythmia recurrence (HR =2.16, CI 1.15-4.06, P = 0.02).
CONCLUSIONS: In patients with ischemic VT, success rate of ablation was highest among patients with preserved LV function and recurrent VT and ES was highest among patients with severe LV dysfunction after single and multiple ablation procedures.
DESIGN: Patients with recurrent VT post infarction who underwent catheter ablation between 2006 and 2017 in Isala Heart Centre were retrospectively analyzed. Univariate and multivariate analysis were used to identify predictors of arrhythmia recurrence post ablation. Patients were allocated to subgroups based on LVEF: severe (< 30%), moderate (30-40%) and mild LV dysfunction (41-51%) and analyzed with log rank test.
RESULTS: A total of 144 patients were included. Two years VT free survival after a single procedure was 56,6% with median follow-up 46 [17-78] months. Recurrence of VT postablation wash high among patients with an old anteroseptal MI and LVEF <30% with multiple morphologies of inducible VTs, indicating an extensive and complex substrate. Patients who underwent repeat ablations (27.1%) had significant more often LV aneurysms (20.5% vs 7.6%, p = 0.03) and electrical storms (38.5% vs 21.9%, p = 0.04). VT free survival was higher in patients with LVEF 41-51% compared to LVEF <30% (71.4% vs 47.8%, p = 0.01). In multivariate analysis, LVEF <30% (vs 41-51%) was an independent predictor of arrhythmia recurrence (HR =2.16, CI 1.15-4.06, P = 0.02).
CONCLUSIONS: In patients with ischemic VT, success rate of ablation was highest among patients with preserved LV function and recurrent VT and ES was highest among patients with severe LV dysfunction after single and multiple ablation procedures.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app